Drugmakers Seek Emergency Authorization For New COVID Vaccine

Drugmakers Seek Emergency Authorization For New COVID Vaccine

Assessment

Interactive Video

Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses the efficacy of a new COVID-19 vaccine by Sanofi and GlaxoSmithKline, which uses a recombinant protein technology. It compares this vaccine to those by Pfizer, Moderna, and Johnson & Johnson, highlighting differences in technology and efficacy rates. The Sanofi-GSK vaccine shows varying effectiveness against different severities of COVID-19. Booster doses significantly increase antibody levels, with notable results from mixing and matching vaccines. The video emphasizes the evolving nature of the virus and the importance of continued research and adaptation.

Read more

1 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What new insight or understanding did you gain from this video?

Evaluate responses using AI:

OFF